Working… Menu

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) (SARPAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04326920
Recruitment Status : Completed
First Posted : March 30, 2020
Last Update Posted : March 2, 2021
Flanders Institute of Biotechnology
Information provided by (Responsible Party):
Bart N. Lambrecht, University Hospital, Ghent